Search Within

Radiation Oncology, Department of

Formats
  1. Journal Article (2434)
  2. Meeting Abstract (2044)
  3. Book Section (299)
  4. Review (187)
  5. Editorial (106)
  6. Correspondence (75)
  7. Guidelines (63)
  8. Research Letter (34)
  9. Conference Paper (31)
  10. Book Whole (8)
  11. Miscellaneous (7)
Groups
  1. Survivorship Research (2239)
  2. Department of Medicine (1589)
  3. Surgery (1352)
  4. Solid Tumor Oncology Division (1188)
  5. Medical Physics (940)
  6. GSK Faculty (924)

More Groups

People
  1. Nancy Lee (896)
  2. Joachim Yahalom (635)
  3. Suzanne Wolden (566)
  4. Yoshiya Yamada (480)
  5. Nadeem Riaz (423)
  6. Abraham Wu (406)

More People

Years
  1. 2026 (1)
  2. 2025 (261)
  3. 2024 (413)
  4. 2023 (365)
  5. 2022 (371)
  6. 2021 (359)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (1494)
  2. Journal of Clinical Oncology (405)
  3. Medical Physics (135)
  4. Radiotherapy and Oncology (128)
  5. Blood (118)
  6. Gynecologic Oncology (110)

More Publications

Publishers
  1. Elsevier Inc. (2047)
  2. American Society of Clinical Oncology (435)
  3. Springer (217)
  4. Wiley Blackwell (194)
  5. Lippincott Williams & Wilkins (189)
  6. Oxford University Press (182)

More Publishers

Results (5288)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EGFR mutations predict superior survival of NSCLC patients with oligometastatic disease treated with local consolidative therapy
    Meeting Abstract

    Farooqi, A.; Mitchell, K.; Ludmir, E.; Boyce-Fappiano, D.; Vaporciyan, A.; Swisher, S.; Zhang, J.; Le, X.; Antonoff, M.; Gomez, D.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Heart dose is a dosimetric predictor of overall survival in patients with NSCLC undergoing post-operative radiation therapy
    Meeting Abstract

    Shepherd, A.; Yu, A.; Al-Sadawi, M.; Peleg, A.; Iocolano, M.; Leeman, J.; Imber, B.; Wild, A.; Offin, M.; Chaft, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • A safety study of avelumab plus SBRT in malignant mesothelioma
    Meeting Abstract

    Rimner, A.; Yorke, E.; Gelblum, D.; Shepherd, A.; Guttmann, D.; Iqbal, A.; Daly, R.; Offin, M.; Fiore, J.; Namakydoust, A.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Randomized phase II trial (RTOG1106) on midtreatment PET/CT guided adaptive radiotherapy in locally advanced non-small cell lung cancer
    Meeting Abstract

    Kong, F.; Hu, C.; Machtay, M.; Matuszak, M.; Xiao, Y.; Ten Haken, R.; Hirsh, V.; Pryma, D.; Siegel, B. A.; Gelblum, D.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • DASL-HiCaP: Darolutamide augments standard therapy for localized very high-risk cancer of the prostate (ANZUP1801) - A randomized phase III double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation
    Meeting Abstract

    Niazi, T.; Williams, S.; Davis, I. D.; Stockler, M. R.; Martin, A. J.; Bracken, K.; Roncolato, F.; Horvath, L.; Martin, J.; Lim, T. S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Social disparities in the diagnosis and management of bladder cancer
    Meeting Abstract

    Hasan, S.; Lazarev, S.; Garg, M.; Press, R. H.; Chhabra, A.; Choi, I.; Simone, C. B.; Gorovets, D.; Mehta, K. J.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Evaluating the role of stereotactic body radiation therapy with respect to androgen receptor signaling inhibitors for metastatic prostate cancer
    Meeting Abstract

    Brennan, V.; Spektor, A.; Sweeney, C.; Choudhury, A. D.; Rathkopf, D. E.; Pomerantz, M.; Hertan, L. M.; Martin, N. E.; Nguyen, P. L.; Balboni, T. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A multicenter phase Ib/II study of DNA-PK inhibitor peposertib (M3814) in combination with capecitabine and radiotherapy in patients with locally advanced rectal cancer
    Meeting Abstract

    Romesser, P. B.; Holliday, E. B.; Philip, T.; Garcia-Carbonero, R.; Capdevila, J.; Tuli, R.; Sarholz, B.; Kuipers, M.; Rodriguez, A.; Diaz-Padilla, I.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Durvalumab (D) and PET-directed chemoradiation (CRT) after induction FOLFOX for esophageal adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Wu, A. J. C.; Sihag, S.; Park, B. J.; Jones, D. R.; Gu, P.; Maron, S. B.; Sugarman, R.; Chalasani, S. B.; Shcherba, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Impact and utility of COLONTOWN, an online CRC patient and caregiver support group in clinical trial design
    Meeting Abstract

    George, M.; Smith, J. J.; Miller, E. D.; Romesser, P. B.; Seybold, N.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save